Other medications : List all other prescription and over-the-counter medications you're taking
Greater weight loss potential The SURMOUNT-5 trial, published in NEJM in 2025, directly compared tirzepatide against semaglutide in adults with obesity (without diabetes)
Some hair shedding is expected, but severe loss may signal inadequate nutrition or an underlying deficiency
This program is designed to help you achieve your health and wellness goals while promoting sustainable lifestyle changes resulting in long-term results
The article attributes specific early weight-loss numbers and a response percentage to a large semaglutide trial, but that trial titrated participants upward rather than holding them at the lowest step, so a step-specific figure is not something the article supports
PlexusDx partners exclusively with licensed 503A compounders, never 503B manufacturers, guaranteeing that medications meet patient-specific safety and efficacy requirements